The management of the Business is delegated by the Board to the Group Chief Executive, who uses various Committees to assist him in this task.
The role of the Executive-level Committees is set out below, with a table showing the membership as at March 2016.
Group Executive Committee
The Committee meets quarterly and is responsible for: developing and implementing strategy, operational plans, policies, procedures and budgets; monitoring operating and financial performance; assessing and controlling risk; and prioritising and allocating resources.
Group Finance Committee
The Committee meets every month to review monthly operating results and examine capital expenditure projects.
Risk Management Committee
The Committee meets quarterly to evaluate and propose policies and monitor processes to control business, operational and compliance risks faced by the Group, and to assess emerging risks.
Group SHEQ Steering Committee
The Committee meets quarterly to monitor progress against the Group SHEQ objectives and targets, review safety performance and audits, and determine the requirement for new or revised SHEQ policies, procedures and objectives.
Routine Business Committee
The Committee comprises the Group Chief Executive and Group Financial Director, with the Group General Counsel and Company Secretary and Group Financial Controller acting as alternates. The Committee attends to business of a routine nature and to the administration of certain matters, the principles of which have been agreed by the Board or the Group Executive Committee.
|Committee Membership||Group Executive Committee||Risk Management Committee||Group SHEQ Steering Committee||Group Finance Committee|
|Steve Foots||Group Chief Executive||Chairman||Member||Member||Chairman|
|Stuart Arnott||President Global Operations||Member||Member||Chairman||Member|
|Sandra Breene||President Personal Care||Member||Member||Member|
|Tom Brophy||Group General Counsel and Company Secretary||Member||Member||Member|
|Nick Challoner||President Asia||Member||Member||Member|
|Anthony Fitzpatrick||President Corporate Development||Member||Member||Member|
|Maarten Heybroek||President Performance Technologies & Industrial Chemicals||Member||Member||Member|
|Keith Layden||Chief Technology Officer & President Life Sciences||Member||Member||Member||Member|
|Jez Maiden||Group Finance Director||Member||Chairman||Member||Member|
|Graham Myers||Group Financial Controller||Member||Member||Member||Member|